The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study)

Abstract Background The oral gonadotropin-releasing hormone antagonist relugolix, which temporarily stops menstruation, is used to treat heavy menstrual bleeding, pelvic pressure, and low back pain in women with uterine fibroids. Treatment can also help women recover from low hemoglobin levels and p...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Mari Kitade, Jun Kumakiri, Hiroyuki Kobori, Keisuke Murakami
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2024-05-01
Saila:	Trials
Gaiak:	Uterine fibroids Leiomyomas Preoperative therapy Intraoperative blood loss Laparoscopic myomectomy GnRH antagonist
Sarrera elektronikoa:	https://doi.org/10.1186/s13063-024-08170-1
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!